Chondroitin sulfate (CS) and dermatan sulfate (DS) are expressed in significant amounts in the brain and play important roles in the development of the central nervous system in mammals. CS and DS structures are often found in a single CS/DS hybrid chain. The L-iduronic acid (IdoA)-containing domain, which defines a DS-type domain, appears key to the biological functions of the CS/DS hybrid chain. In this study, to clarify the distribution of the DS-type structure in the brain during development, the expression patterns of DS epimerase 1 (DS-epi1) and DS-epi2, both of which convert D-glucuronic acid (GlcA) into IdoA, were investigated by in situ hybridization. DS-epi2 was ubiquitously expressed in the developing brain after birth, whereas the expression of DS-epi1 was faint and obscure at all developmental stages. Quantitative real-time PCR revealed the expression of DS-epi2 to be higher than that of DS-epi1 throughout development, suggesting that DS-epi2 but not DS-epi1 is mostly expressed in the brain and plays key roles in the epimerization of CS/DS during its 
Introduction
Chondroitin sulfate (CS) and dermatan sulfate (DS) are sulfated glycosaminoglycans (GAGs), which are linear polysaccharides covalently bound to serine residues of specific core proteins forming proteoglycans (PGs). CS and DS are composed of repeating disaccharide units, GlcA-GalNAc and IdoA-GalNAc (Fig. 1) , where GlcA, IdoA, and GalNAc represent D-glucuronic acid, L-iduronic acid, and N-acetyl-D-galactosamine, respectively. DS is a stereoisomeric variant of CS containing IdoA instead of GlcA residues, and CS and DS are often found in a single polysaccharide chain as a CS/DS hybrid structure (Habuchi et al. 1973; Sugahara and Mikami 2007) . The IdoA-containing disaccharides can be adjacent, forming long blocks, or singly interspersed among GlcA-containing disaccharides (Pacheco et al. 2009b ). The simple disaccharide backbone of CS/DS is modified most notably by sulfation at various positions to form a variety of disaccharide units as shown in Fig. 1 . The combination of these various units provides CS/DS with enormous structural heterogeneity along its length.
CS/DS is mainly distributed in extracellular matrices and at cell surfaces, and plays an important role in many biological functions under physiological and pathological conditions. Accumulating evidence has demonstrated that CS/DS regulates biological processes by interacting with and regulating various functional protein ligands such as growth factors, neurotrophic factors, and cytokines (Sugahara and Mikami, 2007; Yamada and Sugahara 2008) . CS/DS binds to bioactive proteins through oligosaccharide domains composed of specific disaccharide sequences, which may hence greatly influence the functions of CS/DS.
Highly-sulfated CS chains containing D units [GlcA(2S)-GalNAc(6S)] or E units
[GlcA-GalNAc(4S,6S)] show neuritogenic activity Clement et al. 1999) . Defective 6-O-sulfation of CS causes chondrodysplasia and skeletal dysplasia (Thiele et al. 2004; van Roij et al. 2008; Tuysuz et al. 2009 ). The specific sulfation patterns in CS/DS chains appear to be critical to their functions. Studies have shown that IdoA residues are also key factors in the formation of such functional domains. Some bioactive proteins including heparin cofactor II, fibroblast growth factor (FGF)-2, FGF-7, and pleiotrophin require IdoA-containing domains for interaction with CS/DS (Maimone and Tollefsen 1990; Penc et al. 1998; Trowbridge et al. 2002; Bao et al. 2005) .
Recent studies using rodents have demonstrated that thousands of fresh neurons arise even in the adult brain every day particularly in the hippocampus, a structure involved in learning and memory (Shors 2009 ). However, little is known about the molecular basis.
CS/DS chains are implicated in the development of the central nervous system in mammals, in which IdoA residues appear to play important roles. The CS/DS hybrid moieties of a DSD-1-PG isolated from neonatal mouse brain (Faissner et al. 1994) showed neuritogenic activity toward hippocampal neurons in vitro . Highly-sulfated DS polysaccharides purified from various marine organisms also exhibited neuritogenic activity 7 (Hikino et al. 2003; Nandini et al. 2004 Nandini et al. , 2005 Li et al. 2007 Li et al. , 2010 . In addition, CS/DS hybrid chains purified from embryonic pig brains, which displayed remarkable neuritogenic activity, contained a higher proportion of IdoA than those from adult brains, which showed little neuritogenic activity (Bao et al. 2004 ). These results indicate that the DS-type structure exists in the brain and is involved in neuritogenesis. Furthermore, it has recently been reported that IdoA-containing CS/DS chains are concentrated in the elaborating cerebellum after birth, where the cerebellar system is dramatically matured (Mitsunaga et al. 2006) , suggesting the DS-type structure to be involved in the brain's development in vivo.
During the biosynthesis of CS/DS, the polysaccharide backbone of chondroitin composed of alternating GlcA and GalNAc units is constructed first (Kitagawa et al. 2001 . The structural diversity of CS/DS is generated by ensuing modifications such as C5-epimerization and O-sulfation under the control of two DS epimerases (DS-epi1 and DS-epi2), which convert GlcA into IdoA (Maccarana et al. 2006; Pacheco et al. 2009b) , and distinct sulfotransferases (Kusche-Gullberg and Kjellén 2003), respectively. O-Sulfation, which takes place after the C5-epimerization, has been postulated to be involved in the fixation of DS-type structures by preventing back epimerization reactions (Malmström 1984) . (Kobayashi et al. 1999; Mikami et al. 2003 ).
Previously, the expression level of both D4ST-1 and UST was demonstrated to be higher in cerebellum than in whole brain during postnatal development (Mitsunaga et al. 2006 ).
Further, the accumulation of IdoA-containing structures in cerebellum has been observed.
Although C5-epimerization is a rate-limiting step in the biosynthesis of DS, the respective expression of DS-epi1 and DS-epi2 in mouse brain during postnatal development remains to be elucidated. The recently cloned DS-epi1 (coded by the gene Dse) and DS-epi2 (coded by Dse-like (Dsel)) share a highly conserved ~700 amino acid domain of active epimerase (Maccarana et al. 2006; Pacheco et al. 2009b ). In addition, DS-epi2 has a C-terminal domain similar to CS/DS-sulfotransferase (Goossens et al. 2003; Pacheco et al. 2009b) , although its activity remains to be established. In this study, the expression pattern of DS-epi1 and DS-epi2, as well as the structure of CS/DS from the brain during postnatal development, were investigated to gain insights into the distribution and function of the IdoA-containing structures.
Results

Expression of DS-epi1 and DS-epi2 in the mouse brain during postnatal development
The formation of IdoA by C5-epimerization of GlcA is the initial modification of the CS/DS hybrid chain (Malmström 1984) , and catalyzed by two C5-epimerases DS-epi1 and DS-epi2 9 encoded by Dse and Dsel genes, repectively (Maccarana et al. 2006; Pacheco et al. 2009b) . It has been reported that IdoA-containing structures in CS/DS hybrid chains are important for neuritogenic activity (Sugahara and Mikami 2007) and postnatal development of the brain, especially cerebellum (Mitsunaga et al. 2006; Ishii and Maeda 2008) .
To investigate the distribution and function of such structures, the expression patterns of the DS-epi1 and DS-epi2 transcripts were examined by in situ hybridization using 35 S-labeled antisense probes in sagittal sections prepared from mouse brains at postnatal day (P) 7, P14, P21, and 7 weeks (7W) (Fig. 2) . The DS-epi2 transcript was detected in widespread regions including the olfactory bulb, caudate putamen, cerebral cortex, hippocampus, thalamus, midbrain, and cerebellum (Figs. 2, A-D ). In the negative control experiments with the respective 35 S-labeled sense probe, essentially no signal was detected in the sections of P21 (Fig. 2E) , P7, P14, or 7W (data not shown) mice, confirming the specific hybridization of the antisense probe. The widespread expression of DS-epi2 seen at P7 and P14 was more restricted at P21 and 7W. As shown in Figs. 2A and 2B, DS-epi2 was expressed ubiquitously in the mouse brain but its expression was marked in the hippocampus and thalamus in P7 and P14 mice. On the other hand, intense labeling of DS-epi2 was restricted to the hippocampus, thalamus, and cerebral cortex in the brains of P21 and 7W mice ( Fig. 2C and 2D ), indicating that the expression pattern of DS-epi2 in mouse brain changed with postnatal development. In contrast, almost no DS-epi1 was detected at P21 (Fig. 2F ), or at any other stage (data not shown). These results suggest the expression of DS-epi1 to be much lower than that of DS-epi2 in every region and at every stage examined.
The detailed expression pattern of DS-epi2 was further investigated by microautoradiographic analysis (Fig. 3) in the brain section of 7W mice, where intense signals of DS-epi2 were observed in the hippocampus, thalamus, and cerebral cortex by film autoradiography (Fig. 2D) . To identify the cell types expressing DS-epi2, the granule cell layer of the dentate gyrus was counterstained with cresyl violet (Nissl stain) for comparison.
The higher magnification views showed that the signal of the DS-epi2 transcript was detected in the hippocampus ( Fig. 3A and 3C ), thalamus, and caudate putamen (data not shown). In the hippocampus, the predominant signal was observed in the pyramidal cell layer of the CA1-CA3 fields (Fig. 3A) . Although prominent signals of DS-epi2 were also observed in the thalamus and caudate putamen, the cell types expressing DS-epi2 could be hardly identified due to the weak counterstaining by cresyl violet (data not shown).
Consistent with the findings obtained by in situ hybridization (Fig. 2) , quantitative real-time PCR revealed higher levels of DS-epi2 than DS-epi1 in the olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata at all developmental stages (Fig.   4 ). The expression of DS-epi1 showed only moderate changes during development, whereas that of DS-epi2 fluctuated greatly. As shown in Fig. 4B , in cerebrum/midbrain, the highest level of DS-epi2 was observed at P7. The expression of DS-epi2 dropped to a low level at P14, subsequently increased at P21, and then decreased a little at 7W. Similar fluctuations in the expression of DS-epi2 during postnatal development were observed in the other three regions (Figs. 4A, 4C, and 4D). At P7 the expression was higher in cerebrum/midbrain and cerebellum than in the olfactory bulb and pons/medulla oblongata. These findings suggest that DS-epi2, but not DS-epi1, is expressed in mouse brain during the development of the central nervous system, and plays a predominant role in the biosynthesis of the IdoA-containing structures in CS/DS hybrid chains.
Compositional change of CS/DS disaccharides in various regions of the brain during postnatal development
To assess the regional distribution of IdoA-containing units in CS/DS hybrid chains from various regions of the brain in the postnatal period, the disaccharide composition of CS/DS was determined using specific CS/DS-degrading enzymes. GAG-peptide fractions were individually prepared from the olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata of P7, P14, P21, and 7W mice, and an aliquot was digested with chondroitinase (CSase) ABC alone or a mixture of CSases AC-I and AC-II, and subsequently derivatized with a fluorophore, 2-aminobenzamide (2AB). It should be noted that the digestion with CSase ABC was carried out in the buffer mentioned under "Materials and methods" instead of the conventional buffer (50 mM Tris-HCl buffer, pH 8.0, containing 60 mM sodium acetate), so that the efficacy of the 2AB-derivatization of CSase ABC digests would be comparable to that of the digests using a mixture of CSases AC-I and AC-II ( and AC-II can be estimated to be the IdoA-containing structure in CS/DS chains (Habuchi et al. 1973) , and the amount of IdoA-containing disaccharide was calculated as follows: the total amount of disaccharides released by digestion with CSase ABC minus that released by digestion with a mixture of CSases AC-I and AC-II. Although it has been reported that the galactosaminidic linkage adjacent to 2-O-sulfated GlcA [-3GalNAcβ1-4GlcA(2S)β1-] is also resistant to CSases AC-I and AC-II (Yoshida et al. 1993) , a recent study has demonstrated that it is cleavable by CSase AC-II under harsh conditions (Ohtake et al. 2003) .
Representative chromatograms of the digests of CS/DS derived from cerebrum/midbrain with CSase ABC or CSases AC-I and AC-II are shown in Fig. 5 . Similar 13 chromatograms were obtained from other regions (data not shown). The disaccharide composition detected by anion-exchange HPLC is summarized in Fig. 6 . The CS/DS preparations from olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata mainly contained mono-and nonsulfated disaccharide units (Figs. 6A, 6C , 6E, and 6G). The major disaccharide unit in the CS/DS preparations was always the A unit, followed by the C and O units. Although a minute amount of iA was detected, no iC and iO was observed. During the development of all regions of the brain, the proportion of A unit increased, whereas that of C and O units decreased. This developmental change in the sulfation pattern of CS/DS chains was also observed during embryonic development in the chick (Kitagawa et al. 1997 ).
Since a strong signal of the DS-epi2 transcript was observed in the thalamus of a 7W mouse brain (Fig. 2D) , the disaccharide composition of CS/DS in the thalamus was analyzed and compared with that in the cerebral cortex of a 7W mouse brain (Supplementary Table I ).
Although iD and iB units in the cortex were approximately one third of those in the thalamus, the small difference in the ratio of DS disaccharides to CS disaccharides does not appear to be significant, suggesting that the DS-epi2 may not play the critical role in the construction of the IdoA-containing structure but rather the sulfotransferases may mainly contribute to the DS biosynthesis in the brain as discussed later.
The total amount of CS/DS disaccharides in all regions examined decreased with although the total amount of CS/DS in the cerebrum/midbrain and pons/medulla oblongata was significantly reduced (Figs. 6C, 6D , 6G, and 6H). On the opposite, a drastic change in the proportions of disulfated disaccharides in cerebellar CS/DS preparations was observed (Fig.   6F ). During P14 to P21 in the cerebellum, the proportion of iD units decreased by half (Fig.   6F , light gray), whereas that of iB units increased more than four fold (Fig. 6F, light blue) .
The proportions of D and E units were slightly reduced in this region during development (Fig. 6F , dark gray and pink, respectively). Since the cerebellar system dramatically grows after birth, the marked increase in the proportion of IdoA-containing disaccharides in cerebellum CS/DS may be correlated with the postnatal development of the cerebellum as discussed later.
In this study, the ∆B unit was detected in the CSase AC-I and AC-II digests (Figs. 5 and 6), being most likely derived from the B unit not iB unit. The B unit has been detected in shark skin CS/DS (Nandini et al. 2005 ), but never in mammalian tissues. Thus, the presence of the B unit in mammals was reported here for the first time.
Discussion
DS-epimerases convert GlcA to IdoA by catalyzing the C5-epimerization of GlcA residues, which is the initial modifying step in the biosynthesis of IdoA-containing structures in CS/DS.
Two DS-epimerases, DS-epi1 and DS-epi2, coded by the Dse and Dsel genes, respectively, have been identified and characterized (Maccarana et al. 2006; Pacheco et al. 2009b) . DS-epi1
is ubiquitously expressed in vertebrates and at high levels in certain cancer cells (Nakao et al. 2000) . DS-epi2 is also ubiquitously expressed in vertebrates but its highest expression has been shown in the brain where low levels of DS-epi1 have been observed (Goossens et al. 2003 ). This was in good agreement with results of an analysis of DS-epi1-deficient mice (Maccarana et al. 2009 ). The epimerase activity in spleen, kidney, lung, and skin from DS-epi1-deficient mice was less than 35% of that of the corresponding organs of wild-type mice, whereas 86% of the epimerase activity remained in the brain of the homozygous mouse compared with the wild-type. DSEL (DS-epi2) was originally identified as C18orf4, which was genetically associated with manic-depressive disorders (Goossens et al. 2003) , suggesting an indispensable role for DS-epi2 in the brain. In the present study, the expression of DS-epi2
was investigated in various regions of the brain; olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata, and demonstrated to be higher than that of DS-epi1 in every developmental stage examined (Figs. 2 and 4) , indicating that DS-epi2 but not DS-epi1 plays a predominant role in the biosynthesis of IdoA-containing CS/DS structures in the brain.
Two IdoA-containing domains are present in a CS/DS hybrid chain (Fransson and Rodén 1967; Habuchi et al. 1973; Cöster et al. 1975; Sugahara and Mikami 2007) ; an "IdoA block" in which IdoA residues are clustered to form a [IdoA-GalNAc(4S)] n ≥ 4 structure, and a "hybrid structure" where an IdoA residue or a few clustered IdoA residues alternate with GlcA sequence (Michelacci and Dietrich 1974) , suggesting that such disulfated disaccharides form the hybrid CS/DS structure in mouse brain and that long "IdoA blocks", detected as iA, were a minor component.
Although DS-epi2 is widely expressed in the brain (Figs. 2 and 4) , IdoA-containing structures were more concentrated in the cerebellum than in other regions examined (Fig. 6 ), consistent with a previous report (Mitsunaga et al. 2006) . The ratio of DS to CS in the GAG preparation from the thalamus of a 7W mouse brain, where DS-epi2 is highly expressed, was not significantly higher than that from other regions in the mouse brain (Supplementary Table   I ). These findings may be due to the expression of the sulfotransferases catalyzing O-sulfation subsequent to C5-epimerization. In the biosynthesis of iB units, GalNAc-4-O-sulfation takes place immediately after C5-epimerization of GlcA resulting in production of the iA unit by D4ST-1, which mainly contributes to the 4-O-sulfation of GalNAc adjacent to IdoA . UST, then, efficiently catalyzes the 2-O-sulfation of the IdoA residue of iA, forming the iB unit (Kobayashi et al. 1999) . The preferential expression of D4ST-1 and UST in the cerebellum during postnatal development has been reported (Mitsunaga et al. 2006; Ishii and Maeda 2008) , suggesting a positive correlation with the relatively large proportion of iB units in cerebellar CS/DS chains compared to other regions (Fig. 6 ). D4ST-1 and/or UST might be a rate-limiting factor for the formation of IdoA-containing disaccharide units.
The 4-O-sulfation is believed to prevent the epimerization of newly formed IdoA back into
GlcA (Malmström 1984) . In fact, the knockdown of D4ST-1 led to a significant reduction in
IdoA residues (Pacheco et al. 2009a ). Since the presence of iO units has not been clearly demonstrated so far for any animals, O-sulfation may be required for the fixation of DS-type disaccharides. Recently we and others have discovered new types of human Ehlers-Danlos syndrome with D4ST-1 deficiency, where DS in skin fibroblasts of the patients is completely replaced by CS (Dündar et al. 2009; Miyake et al. 2010) . No 4-O-sulfation of GalNAc resdiues most likely cannot prevent the epimerization of newly formed IdoA back into GlcA.
Interestingly, the decorin proteoglycan with a CS chain but without a DS chain of the patient was shown, which possibly leads to decreased flexibility of collagen bundles (Miyake et al. 2010) , manifesting the characteristic symptoms including joint and skin laxity and tissue fragility.
Although the IdoA-containing disulfated disaccharides, iB and iD units, were observed during embryonic development of the mouse brain, their respective precursors, iA and iC units, were hardly detected (Fig. 6) . The 2-O-sulfation of IdoA might have occurred prior to or almost simultaneously with the 4-O-or 6-O-sulfation of GalNAc. UST can also transfer sulfate groups to IdoA residues adjacent to nonsulfated GalNAc residues (Kobayashi et al. 1999) . O-Sulfotransferases involved in the biosynthesis of CS/DS might interact with each other and co-localize in the Golgi lumen. Enzymes of GAG biosynthesis are believed to work as complexes, to facilitate the transfer of the polysaccharide substrate from one enzyme to the following one efficiently (Esko and Selleck 2002) . In fact, physical interactions between pairs of biosynthetic enzymes of heparan sulfate have been shown to influence their enzymatic activities (McCormick et al. 2000; Senay et al. 2000; Pinhal et al. 2001; Presto et al. 2008) . In CS biosynthesis, it has been also demonstrated that chondroitin's polymerization is accomplished by multiple combinations of chondroitin synthase-1 (ChSy-1), ChSy-2, ChSy-3, and chondroitin-polymerizing factor Izumikawa et al. 2007 Izumikawa et al. , 2008 .
Although no direct interaction has been detected between D4ST-1 and either or both of the DS-epimerases in overexpression experiments (Pacheco et al. 2009a) , the possibility cannot be excluded that other enzymes or components associate with them to form a large enzyme complex.
The total amount of CS/DS per mg of acetone powder in every brain region examined decreased during postnatal development (Fig. 6) . The reduction in the cerebrum/midbrain and pons/medulla oblongata was more drastic (Figs. 6C and 6G) than that in the olfactory bulb and cerebellum (Figs. 6A and 6E) . This observation might be closely correlated with the maturation of the brain. The former regions grow during embryonic development, whereas the latter develop dramatically after birth (Rodier 1977) . The minute reduction in the amount of CS/DS in the olfactory bulb and cerebellum with postnatal development may reflect the importance of CS/DS in the postnatal development of the brain. Furthermore, the sulfation profiles of CS/DS chains derived from every region changed with postnatal development (Fig.   6 ). Notably, marked temporal changes, an increase in iB units and a decrease in iD units, were observed in the cerebellum (Fig. 6F) . Although the exact biological significance of the developmental changes in the sulfation profile is still unclear, it is possible that they affect the ability of CS/DS chains to interact with functional proteins.
IdoA-containing disulfated disaccharides were present at significant levels in every region examined in this study (Fig. 6) , and DS-epi2 seems to predominantly contribute to the biosynthesis of such disaccharide units in the mouse brain (Fig. 4) . The structural functions of
IdoA include giving flexibility of CS/DS chains, providing substantial conformational diversity, and facilitating the interaction of the sugar chains with proteins (Casu et al. 1988; Ferro et al. 1990) . A large number of functional proteins require IdoA-containing structures in CS/DS chains for their binding (Maimone and Tollefsen 1990; Penc et al. 1998; Trowbridge et al. 2002; Bao et al. 2005; Li et al. 2007 ). However, it remains to be investigated how the 21 IdoA-containing disulfated disaccharides regulate the functions of these proteins, which are involved in the development and maturation of the brain.
Materials and methods
Materials
The following sugars and enzymes were purchased from Seikagaku Corp. (Tokyo, Japan): six 
Cloning of mouse cDNA encoding DS-epi1 and DS-epi2
Single stranded cDNA was synthesized by reverse transcription using total RNA from normal 
In situ hybridization
Brains were quickly removed from ddY mice at P7, P14, P21, and 7W, and frozen in powdered dry ice. Consecutive brain sections were cut 16-µm thick with a Cryostat CM3050S
(Leica Microsystems, Wetzlar, Germany) at OPEN FACILITY, Hokkaido University Sousei
Hall, then thaw-mounted onto 3-aminopropyltriethoxysilane-procoated glass slides (Matsunami, Osaka, Japan), and stored at -80 °C prior to use.
35
S-Labeled riboprobes were transcribed using the MAXIscript ○ R SP6/T7 kit (Ambion, Austin, TX) with uridine 5'-α[ 35 S]thiotriphosphate (~46.2 TBq/mmol) (PerkinElmer Life and Analytical Sciences, Waltham, MA) and in situ hybridization with 35 S-labeled riboprobes was performed as described previously (Mitsunaga et al. 2006 ).
To identify DS-epi2-expressing cells in brain, a microautoradiographic analysis was performed. After hybridization with 35 S-labeled riboprobes, the slides were dipped in an emulsion (NTB, Kodak, Rochester, NY) following the instructions of the manufacturer.
Subsequently, the slides were exposed for 6 weeks at 4 °C in a light-tight box, and then they were developed with D-19 (Kodak). For microscope observation, the slides were counterstained with cresyl violet (Sigma, St. Louis, MO).
Quantification of the expression of DS-epi1 and DS-epi2 in the brain by real-time PCR
Brains were separated into four parts; the olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata, and used individually for the experiments. Total RNA was extracted from the brain samples using an RNA isolation kit, illustra RNAspin Midi (GE Healthcare, Buckinghamshire, UK). Each cDNA was synthesized from ~1 µg of the total RNA using Moloney murine leukemia virus-reverse transcriptase (Promega) and an oligo(dT)16 primer (Hokkaido System Science, Sapporo, Japan). The primer sequences used were as follows: 
Extraction of GAGs from various regions of the mouse brain at different stages of postnatal development
The olfactory bulb, cerebrum/midbrain, cerebellum, and pons/medulla oblongata of ddY mice at P7, P14, P21, and 7W were dehydrated and delipidated by homogenization in ice-cold acetone, and dried in a desiccator. The number of mice used was 20, 20, 20 and 10,
respectively. Approximately 20-800 mg of the dried material was recovered, and GAGs were extracted as described previously (Nandini et al. 2005) . The thalamus and cerebral cortex were also dissected from 5 mice at 7W for the GAG analysis. The recovery of GAGs was determined with a carbazole reaction to measure uronic acids colorimetrically (Bitter and 25 Muir 1962) .
Analysis of the disaccharide composition of CS/DS
The disaccharide composition of CS/DS in the GAG-peptide preparations from brain samples was determined as follows. The GAG-peptide preparations were dissolved in water and an aliquot (0.1-0.4 % of starting materials) was treated with CSase ABC (Yamagata et al. 1968) (10 mIU) or a mixture of CSases AC-I (Yamagata et al. 1968 ) and AC-II (Hiyama and Okada 1975) (1 and 5 mIU, respectively) in a total volume of 20 µl of 50 mM Tris-HCl buffer, pH 7.3, at 37 °C for 1 h. The enzyme solutions were dried and subjected to derivatization with a fluorophore 2AB as described previously (Kinoshita and Sugahara 1999) . After the removal of excess 2AB reagent by extraction with chloroform, the resultant 2AB derivatives of unsaturated disaccharides were analyzed by anion-exchange HPLC on an amine-bound silica PA03 column (4.6 x 250 mm, YMC Corp., Kyoto, Japan) with a linear gradient of NaH2PO4 from 16 to 540 mM over 60 min at a flow rate of 1 ml/min. Identification and quantification of the disaccharides were achieved by comparison with the positions and fluorescence intensity of CS-derived authentic unsaturated disaccharides; ∆O, ∆C, ∆A, ∆D, ∆B, and ∆E.
The amount of IdoA-containing disaccharides was calculated as follows: the total amount of disaccharides released by CSase ABC minus the amount released by a mixture of CSases AC-I and AC-II. Th, thalamus; Md, midbrain; Cpu, caudate putamen. Scale bar, 5 mm. Py, pyramidal cell layer; GrDG, granule cell layer of the dentate gyrus. was individually normalized to that of glyceraldehyde-3-phosphate dehydrogenase (G3pdh).
The assay was performed at least twice in duplicate, and representative results are shown.
Values represent the mean ± S.D. ∆D; 5, ∆B; 6, ∆E. The peaks marked by asterisks correspond to the 2AB-labeled ∆HexA-GlcNAc derived from hyaluronic acid, which was also digested by bacterial CSases (Linhardt et al. 2006; Petit et al. 2006) . The CS/DS chains in the GAG-peptide preparations from olfactory bulb (A and B), cerebrum/midbrain (C and D), cerebellum (E and F), and pons/medulla oblongata (G and H)
